Hacker News Reader

I was talking to someone who’s on a similar medication and they were having an equally hard time getting it filled.

I wonder if the issues fulfilling the orders of the actual drug product or the overly complex (and highly wasteful) drug delivery mechanism.?

View on HN

Pretty sure they can’t manufacture enough of the drug itself.

Novo Nordisk is running their lines at max capacity and cutting production of some other drugs. I think the last number I saw was new weekly prescriptions are up 3x from Dec 2023.

Unlike Eli Lilly (who use chemical synthesis for Zepbound) they use yeast for synthesis and have decided not to contract out production to protect manufacturing trade secrets which makes ramping up slower, have to wait for their Denmark plant upgrade to come online.

Reply on news.ycombinator.com